Lipid pathway alterations in Parkinson's disease primary visual cortex - Wikidata - wikimedia - TriplyDB

Lipid pathway alterations in Parkinson's disease primary visual cortex

Lipid pathway alterations in Parkinson's disease primary visual cortex

http://www.wikidata.org/entity/Q28386548

about

Oxysterols in the pathogenesis of major chronic diseases Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus.Reduced neonatal mortality in Meishan piglets: a role for hepatic fatty acids?Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus Applying mass spectrometry-based qualitative proteomics to human amygdaloid complex.Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells.The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease.Lipid profiling of parkin-mutant human skin fibroblasts.Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson's Disease Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders Food-induced changes of lipids in rat neuronal tissue visualized by ToF-SIMS imaging.Disturbed phospholipid homeostasis in endoplasmic reticulum initiates tri-o-cresyl phosphate-induced delayed neurotoxicity A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV Lipidomics applications in health, disease and nutrition research.Signal transducer and activator of transcription 2 (STAT2) metabolism coupling postmitotic outgrowth to visual and sound perception network in human left cerebrum by biocomputation.Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease.The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.Evidence for altered cholesterol metabolism in Huntington's disease post mortem brain tissue.Neuronal Cholesterol Accumulation Induced by Cyp46a1 Down-Regulation in Mouse Hippocampus Disrupts Brain Lipid Homeostasis Comprehensive identification of age-related lipidome changes in rat amygdala during normal aging Protective effect of arachidonic acid and linoleic acid on 1-methyl-4-phenylpyridinium-induced toxicity in PC12 cells.Imaging of neuronal tissues by x-ray diffraction and x-ray fluorescence microscopy: evaluation of contrast and biomarkers for neurodegenerative diseases.Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains.Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis.Effects of dietary glucocerebrosides from sea cucumber on the brain sphingolipid profiles of mouse models of Alzheimer's disease.Lipidomic analysis of p-chlorophenylalanine-treated mice using continuous-flow two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry.Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies.Comprehensive gene expression analyses of the rat prefrontal cortex after oxysterol treatment.Cortical and subcortical brain atrophy in Parkinson's disease with visual hallucination.Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis.Alteration in Fluidity of Cell Plasma Membrane in Huntington Disease Revealed by Spectral Phasor Analysis.Molecular composition of the human primary visual cortex profiled by multimodal mass spectrometry imaging.Microarray Analysis of the Molecular Mechanism Involved in Parkinson's Disease.27-Hydroxycholesterol increases α-synuclein protein levels through proteasomal inhibition in human dopaminergic neurons.Oxysterol levels and metabolism in the course of neuroinflammation: insights from in vitro and in vivo models.Absent Audiovisual Integration Elicited by Peripheral Stimuli in Parkinson's Disease.

P2860

Q26864594-6BA06405-5CEE-4FE4-8E08-C06B76711F0C Q27313143-03E06FB2-C9A3-4C63-A6DF-E9D6F8EB83DB Q28485177-3AE7FFB6-E2BA-455B-AB77-665B7C0340E8 Q30588683-0973B833-2451-4A3A-9D49-4D8DFB38673F Q35136493-2FEC5613-BBAD-47A6-B447-06EA18ED8202 Q35225919-D9769806-6561-40F6-8241-E796443C8A05 Q35492403-A007F78C-9A21-4F76-AD15-608048E0E6B7 Q35552497-FDBB6B0B-2575-4C00-8134-F999E8236E1B Q35710041-E9AD2807-1713-4F8C-A5C8-C1640DEC16ED Q35952063-512C0385-92E8-4E23-A9D2-16B5515F935E Q36060128-E8358334-13D3-4C5E-A19F-2FDC74FA958F Q36256274-CA89AEDA-3C48-4EB2-86CD-E133EF4238D7 Q36983489-BBAF4B81-A7BE-4702-BDC6-A15E80B83AF6 Q37199221-4382CA1B-EABC-4060-9A7D-3D14D557B961 Q37232858-B8C5DE40-C393-4AB8-9524-0A4738750014 Q37435130-3B2E3DFB-F01E-41A4-834E-094C5441BC35 Q37541514-24DD7C76-C576-4B89-BF64-653059ABBC15 Q38111301-7362FE31-4060-40C5-9F57-170FD9C49CB5 Q38499010-028E3A66-826D-4492-BF96-4BBD9D010E27 Q39193441-1DA5BD5D-F882-466E-A173-D947EBC86AD8 Q39410832-504FD15A-B8C5-470B-B19F-834E82F03772 Q40536177-51AFE66C-B209-438C-B2F1-365A7B50ECC5 Q40974852-0A4AA9A5-4C0C-44B5-9916-3842AE65A7E3 Q41739566-BEF8419F-778F-4648-B934-6AC6FB81F718 Q42238650-A5DF383B-792D-43ED-B041-B44793C7187F Q42639638-27584965-8379-4816-85F1-4723CAB8BE34 Q44185145-D4170759-DCB9-4699-890B-315BC1DD3511 Q45291729-7EFA496F-956E-4EAA-ACC6-B7349BA34FF2 Q46413209-D8B4C02F-098C-43EE-9A72-6D8C65719084 Q46694997-79F6DE77-2C39-4622-B3ED-B39B94D74BDE Q48189615-8723AED5-9FF7-476A-A2EF-AA69B621DBF1 Q48223027-0899F3F3-81F5-42FD-AB47-BC5F16B2B3D6 Q48917647-181A5E20-7C76-4603-85F8-B0299FBAC755 Q49452570-93145EC1-5D58-4528-BC71-1FBFA4FB9984 Q49475422-5A5311AA-B73F-480A-B372-191B31FEB9BF Q52597361-9242F09D-A246-407D-8AA9-0EA2FE5A0C0D Q54979603-B4F1522D-1C37-4678-B1AE-BF00DC141497 Q55236585-372A81C8-F30B-4A55-A944-1D2F057256A9 Q55248842-86B396FF-E917-43BC-A27E-73E4082D9AF4 Q55380037-77B7F443-3825-473D-921A-11B13AA4A076

P2860

Lipid pathway alterations in Parkinson's disease primary visual cortex

http://www.wikidata.org/entity/Q28386548

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Lipid pathway alterations in Parkinson's disease primary visual cortex

@ast

Lipid pathway alterations in Parkinson's disease primary visual cortex

@en

Lipid pathway alterations in Parkinson's disease primary visual cortex

@nl

type

label

Lipid pathway alterations in Parkinson's disease primary visual cortex

@ast

Lipid pathway alterations in Parkinson's disease primary visual cortex

@en

Lipid pathway alterations in Parkinson's disease primary visual cortex

@nl

prefLabel

Lipid pathway alterations in Parkinson's disease primary visual cortex

@ast

Lipid pathway alterations in Parkinson's disease primary visual cortex

@en

Lipid pathway alterations in Parkinson's disease primary visual cortex

@nl

P1433

Q28386548-D9921E25-2350-4423-9487-C6504130BDFA

P1476

Q28386548-214D2BB2-4544-418B-861F-78BAA86495EA

P2093

Q28386548-0887DABF-6383-45C3-BD5B-D0E6A45BDCFB

Q28386548-341DFFC9-BBB9-42CD-8DE6-8774E1B50525

Q28386548-3CA9B326-E9EF-4964-A409-A2DCD0F5E372

Q28386548-5EDC8EEE-B7AB-42BC-941B-04E93826013A

Q28386548-629D1E42-482E-44B6-AD92-ACBB617FB06E

Q28386548-6E46DD87-4870-4EA1-B659-50DC85CE2C0E

Q28386548-98C02C97-9BCC-4EAA-A3D4-433C9DEA7D1E

Q28386548-C5698BE0-2228-4EDB-AA43-D5BC12288765

Q28386548-F8FBF134-011F-4974-8DC7-17C1C026A5D3

P2860

Q28386548-023FF3F1-E459-4BD2-8E0F-C5298E1E6F68

Q28386548-08545C52-A14E-4FB9-AAD2-F8F51E424B35

Q28386548-09CBAB32-FF0E-40CA-91C9-DF4C4AF25980

Q28386548-0C2608B8-59DF-4484-BC7C-F58F6CE1DA99

Q28386548-0C9D5116-0C78-4999-BF0B-9289032E41E9

Q28386548-0E22191A-F1B0-4452-B738-A9AD8DDD5DC6

Q28386548-110A19B0-7F24-415E-8428-B86137DD13D7

Q28386548-11821A7A-1ADD-47B2-80AA-573BD6284BDA

Q28386548-1299D74E-0349-4CB6-938A-F11A0CD34536

Q28386548-161E0F46-8A3F-405A-B663-90DC19C44EA5

P304

Q28386548-47ABAD6E-D53B-4894-82A4-60ABE21E7C00

P31

Q28386548-5B0795AE-FAD6-4904-8703-70954F5EADD0

P3181

Q28386548-740A7260-52E7-4586-89E2-DFFADE97E43B

P356

Q28386548-1D4884D0-ABBE-4D78-B61D-607B739AB76E

P407

Q28386548-8932C1FF-6595-449A-87AA-77BBD7CE5D9F

P433

Q28386548-7EC4E00E-6B92-4285-AE2E-226567989DAC

P478

Q28386548-34225160-F563-47E2-ADB0-B5D5124233BD

P50

Q28386548-23717698-6011-4712-A2D1-880C7F185156

Q28386548-AC70F509-472D-43D8-BF43-FBBA0172E271

P577

Q28386548-13EAB75E-E473-4B96-97F0-B27727E813AD

P5875

Q28386548-F32383F1-42A8-45D8-AC9D-F043A7CBB1E6

P698

Q28386548-BA7BD630-085B-4759-9C06-BBB3D276ED2F

P921

Q28386548-DEB2901E-C51D-43A0-8441-AD4E9AC5792D

P932

Q28386548-4F043547-B488-4EDB-949A-9C080FC85065

P3181

P356

JOURNAL.PONE.0017299

P1433

P1476

Lipid pathway alterations in Parkinson's disease primary visual cortex

@en

P2093

Andrew M Jenner

http://www.w3.org/2001/XMLSchema#string

Brett Garner

http://www.w3.org/2001/XMLSchema#string

Danni Cheng

http://www.w3.org/2001/XMLSchema#string

Guanghou Shui

http://www.w3.org/2001/XMLSchema#string

Heather McCann

http://www.w3.org/2001/XMLSchema#string

Jessica R Nealon

http://www.w3.org/2001/XMLSchema#string

Markus R Wenk

http://www.w3.org/2001/XMLSchema#string

Wei Fun Cheong

http://www.w3.org/2001/XMLSchema#string

Woojin S Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Missing pieces in the Parkinson's disease puzzle

Mass-spectrometry based oxidative lipidomics and lipid imaging: applications in traumatic brain injury

Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies

Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration

24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

Hallucinations, delusions, and cognitive decline in Alzheimer's disease

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

A combined transcriptomics and lipidomics analysis of subcutaneous, epididymal and mesenteric adipose tissue reveals marked functional differences

Alpha-synuclein in Lewy bodies

P304

e17299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

558280

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0017299

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Glenda Halliday

Todd W Mitchell

P577

2011-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50349124

http://www.w3.org/2001/XMLSchema#string

P698

21387008

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3046155

http://www.w3.org/2001/XMLSchema#string